Eli Lilly’s Triple Combo Obesity Drug Tops 28% Weight Loss in a Pivotal TrialNews DeskMay 21, 20260 Next-generation obesity drugs are testing combination approaches intended to lead to greater weight reduction and one of them, an experimental…